ARCHIVES

Overdiagnosis Can Result In Harm To Patients, Experts Say.

This article is from The Cancer Letter archive.

Vol. 32 No. 39 | November 3, 2006

Download PDF Visit The Full Archive

Related Articles

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

November 29, 2002

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

Nexavar Improves PFS In Phase III Trial

January 25, 2013

Walter Reed Oncologic Pharmacy Residency Program Has Openings

November 25, 1988

In Brief: Day, Foti Lead Coalition; Harkin Ends Campaigns; UT Southwestern Recieves $85 Mil. In Donations

March 13, 1992

Agencies Plan Better Reporting Of Adverse Events In Trials.

February 4, 2000